Characterization of Weaning Practices in ICUs of Global South Countries

February 11, 2026 updated by: Hospital do Coracao

Characterization of Weaning Practices in ICUs of Global South Countries: A Prospective Observational Study

This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Data will be collected for each patient during the first 7 days after extubation, with follow-up until hospital discharge or death. We plan to conduct the study in intensive care units from Global South countries (low- and middle-income countries predominantly located in the Southern Hemisphere, though some in the Northern Hemisphere are also considered).

Study Overview

Study Type

Observational

Enrollment (Estimated)

900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients receiving mechanical ventilation for more than 12 hours who are planning to undergo the first separation attempt from the invasive mechanical ventilation (as defined in the WIND Classification) in the next 6 hours or that has undergone a separation attempt less than 2 hours ago will be included.

Description

Inclusion Criteria:

  • Age > 18 years.
  • Receiving care at an intensive care unit.
  • Endotracheal intubation.
  • Mechanical ventilation for 12 hours or more.
  • First separation attempt, as defined in the WIND Classification - "Separation attempt from mechanical ventilation: an spontaneous breathing trial with or without extubation, or an extubation directly performed without identified spontaneous breathing trial (whatever the type: planned or unplanned extubation)" - planned to occur in the next 6 hours or that occurred less than 2 hours ago.

Exclusion Criteria:

  • Patients with prior extubation failure.
  • Patients with prior spontaneous breathing trial failure.
  • Patients unable to obey commands.
  • Neuromuscular disease or cervical spinal cord injury.
  • Tracheostomy.
  • Do-not-resuscitate order or contraindication for reintubation.
  • Lack of informed consent.
  • Terminal extubation.
  • Previously included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extubation failure within 7 days.
Time Frame: 7 days.
Defined as reintubation or death within 7 days after extubation.
7 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extubation within 28 days.
Time Frame: 28 days.
Defined as extubation within 28 days after first separation attempt.
28 days.
Intensive care unit length of stay.
Time Frame: At intensive care unit discharge, up to 28 days.
Defined as the number of days from the time of first separation attempt until discharge from the intensive care unit.
At intensive care unit discharge, up to 28 days.
Hospital length of stay.
Time Frame: At hospital discharge, up to 28 days.
Defined as the number of days from the time of first separation attempt until discharge from the hospital.
At hospital discharge, up to 28 days.
Reintubation or death within 28 days.
Time Frame: 28 days.
Defined as composite criterion of reintubation or death within 28 days after first separation attempt.
28 days.
Intensive care unit mortality.
Time Frame: At intensive care unit discharge, up to 28 days.
Defined as mortality from the time of first separation attempt until discharge from the intensive care unit.
At intensive care unit discharge, up to 28 days.
Hospital mortality.
Time Frame: At hospital discharge, up to 28 days.
Defined as mortality from the time of first separation attempt until discharge from the hospital.
At hospital discharge, up to 28 days.
Number of spontaneous breathing trials.
Time Frame: 28 days.
Defined as the number of spontaneous breathing trials performed after first separation attempt.
28 days.
WIND classification.
Time Frame: 28 days.
Group 1 (short weaning): the first separation attempt resulted in a termination of the weaning process within 24 hours (successful separation or early death). • Group 2 (difficult weaning): weaning was terminated after more than 1 day but in less than 1 week after the first separation attempt (successful separation or death). • Group 3 (prolonged weaning): weaning was still not terminated 7 days after the first separation attempt (by success or death).
28 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

December 23, 2025

First Submitted That Met QC Criteria

January 7, 2026

First Posted (Actual)

January 13, 2026

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 11, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weaning Failure

Subscribe